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Abelson murine leukemia virus (A-MuLV)-transformed cells, simian virus 40
(SV40)-transformed cells, and chemically transformed cells all have increased
levels of a 50,000-molecular-weight host cell protein. The protein was detected
with sera raised to the A-MuLV-transformed and chemically transformed cells
and was tightly bound to T-antigen in extracts of SV40-transformed cells. Partial
protease digests showed that the proteins from all three sources were indistin-
guishable. The three proteins were phosphorylated in cells, and the linkage of
phosphate to the A-MuLV-associated P50 was to a serine residue. By immunoflu-
orescence methods, P50-related protein was found on the surface of both normal
lymphoid cells and A-MuLV-transformed lymphoid cells, but cell fractionation
showed that the majority of P50 was free in the cytoplasm of the transformed
cells. Immunofluorescence also showed that P50 was found in granules in the
cytoplasm of both untransformed and SV40-transformed fibroblasts. Other cells
gave indistinct patterns. Cocapping experiments showed that the A-MuLV-spec-
ified P120 protein is weakly associated with the surface P50-related protein of
lymphoid cells, but no association of P120 and P50 could be demonstrated by
immunoprecipitation methods. Although a monoclonal antiserum to P50 was
used in many of these studies, the identity of the bulk P50 protein with the
molecules that are reactive at the cell surface requires further study.
Mice bearing an Abelson murine leukemia
virus (A-MuLV)-induced syngeneic tumor often
make antibodies against a 50,000-molecular-
weight phosphorylated host cell protein (23).
This protein, called P50, is abundantly present
in A-MuLV-transformed lymphoid cells and is
at higher concentration in A-MuLV-transformed
fibroblastic cells (NIH/3T3) than it is in normal
NIH/3T3 cells. The monoclonal antibody, RA3-
2C2, reacts with P50 and also reacts with the
surface of normal B-lymphocytes (23; R. Coff-
man and I. Weissman, submitted for publica-
tion).
Accentuation of the concentration of specific
phosphorylated host cell proteins of approxi-
mately 50,000 molecular weight has been re-
ported for cells transformed by the oncogenic
virus simian virus 40 (SV40), in the methylcho-
lanthrene-induced fibrosarcoma called Meth A,
and in a variety of other tumor cells (3, 5, 6, 8,
11, 13, 15-19, 25, 26). In SV40-transformed cells,
the P54 protein is recovered in a complex with
the nuclear SV40 T-antigen (15, 16, 18), and
fluorescent-antibody detection ofthe protein has
usually localized it to the nucleus (8, 19).
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We have examined whether the 50,000-molec-
ular-weight proteins in cells transformed by A-
MuLV, SV40, and methylcholanthrene are re-
lated proteins. We have found apparent identity
between the proteins found in these three sys-
tems. We have also shown that phosphate is
linked to a serine residue in P50. Using fluores-
cence methods, we have found P50-related an-
tigen on the surface of pre-B-lymphoid tumor
cells but not on the surface of transformed fibro-
blasts. The bulk of P50, however, is in the cytosol
oflymphoid cells. Fibroblasts often show antigen
in a granular pattern in the cytoplasm.
MATERIALS AND METHODS
Mice and cell lines. BALB/cN female mice from
our colony, 8 to 12 weeks old, were used.
A-MuLV-transformed lymphoid cell lines of
BALB/c origin, 2M3 and its Moloney MuLV-super-
infected derivative 2M3/M (30), as well as the C57L-
derived L1-2 line (29), were grown in RPMI-1640 plus
10% heat-inactivated fetal calf serum and 2 x 10' M
,l-mercaptoethanol. Other cell lines were grown in
Dulbecco-modified Eagle medium plus 10% calf serum.
They included 70Z, a BALB/c-derived, chemically
transformed pre-B-lymphoid cell line (20); NIH/3T3
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cells; ANN-1, an NIH/3T3-derived line transformed
by A-MuLV (24); SVT2, an SV40-transformed BALB/
3T3-derived line (1) obtained from A. Levine, State
University of New York, Stony Brook; and Meth A, a
chemically-induced fibrosarcoma from BALB/c mice
(6) obtained from A. DeLeo, Sloan-Kettering Institute,
New York, N.Y.
Immune sera. Ab-TB serum was obtained from
BALB/c mice bearing a 2M3/M tumor. Tumor-bear-
ing mice were bled 3 to 4 weeks after tumor appear-
ance. Sera that contained high titers of anti-P50 anti-
bodies were pooled and used in these experiments (23).
Anti-SV40 serum was a gift of A. Levine. Anti-Meth
A serum was provided by A. DeLeo. RA3-2C2 were
monoclonal rat antibodies that immunoprecipitated
P50 from A-MuLV-transformed cell lysates (23). Anti-
AbT serum, containing antibodies that immunoprecip-
itated the P120 ofA-MuLV-transformed cell lines, was
prepared as described previously (29). Goat anti-Mo-
loney MuLV serum reacting with all of the virion
proteins was provided by the Division of Cancer Cause
and Prevention, National Cancer Institute. Fluores-
cein-labeled anti-rat immunoglobulin, rhodamine-la-
beled anti-mouse immunoglobulin, and fluorescein-la-
beled anti-goat immunoglobulin were prepared from
sera made in rabbits and were purchased from Cappel
Laboratories. The rabbit anti-mouse rhodamine serum
was purified on mouse immunoglobulin-Sepharose 4B,
and the other fluorescent sera were all cross-absorbed
on mouse immunoglobulin-Sepharose 4B. Mouse anti-
SV40 large T-antigen was a gift of A. Levine.
Immunofluorescence analysis. Surface staining
of lymphocytes in suspension by using an indirect
immunofluorescent assay was carried out as described
(21); the fibroblastic cells were grown on glass cover
slips and labeled as living monolayers.
For cocapping studies, the cells were incubated with
the first antiserum for 25 min at 37°C, then washed
twice and suspended in fresh medium with the appro-
priate fluorescent rabbit antiserum for about 60 min
at 37°C. The cells were again washed twice, suspended
in medium containing 0.2% sodium azide at 4°C, and
labeled at 4°C for the presence of the second protein.
For intracellular staining, fibroblastic cells were
grown on glass cover slips, or, in some instances, Meth
A and ANN-1 cells were allowed to settle onto cover
slips coated with poly-L-lysine (Sigma type V) to in-
duce the cells to spread out. Lymphocytic cells were
smeared by using a Shandon-Elliott cytospin, and all
cell types were washed in cold phosphate-buffered
saline (PBS). Cells were fixed for 20 min in 3.7%
formaldehyde in PBS at room temperature, washed in
cold PBS, and then permeabilized in acetone-PBS (1:
1) for 2 min at 4°C, in acetone for 5 min at 4°C, and
finally in acetone-PBS (1:1) for 2 min at 4°C, before
being washed in cold PBS. The fixed cells were incu-
bated with each serum for 25 min at room temperature
in a damp chamber. After washing, 1 drop of solution
containing 1 part glycerol, 1 part PBS, and 3.5% form-
aldehyde was added to each smear, which was then
mounted over a microscope slide. Cells were examined
under a standard 18 Zeiss fluorescence microscope.
Cell labeling and immunoprecipitation. Radio-
active chemicals were purchased from New England
Nuclear Corp., Boston, Mass. 2M3 cells were washed
several times with PBS and suspended in labeling
medium at a concentration of 10 x 106 to 15 x 106 cells
per 2 ml. The fibroblastic cell lines were grown to
almost confluence in 10-cm sterile plates. Monolayers
were washed several times with PBS, and 3 ml of
labeling medium was added. When labeled with
[35S]methionine, cells were incubated with Dulbecco-
modified Eagle medium without methionine, supple-
mented with 5% dialyzed fetal calf serum and 125 ,uCi
of [3S]methionine per ml for 1 h at 37°C. When
labeled with 'PO4, cells were resuspended in Dul-
becco-modified Eagle medium without P04 and en-
riched with 5% fetal calf serum; 300 uCi of 'PO4 was
added, and the mixture was incubated for 5 to 16 h at
37°C. Labeled cells were washed in PBS, and either
the pellets of cells or the monolayers were extracted
into 5 ml of lysis buffer: 10 mM NaHPO4-Na2HPO4
(pH 7.5), 100mM NaCl, 1% Triton X-100, 0.5% sodium
deoxycholate, and 0.1% sodium dodecyl sulfate (SDS)
at 0°C; 1 mM phenylmethylsulfonyl fluoride (Sigma)
was then added. Cell lysates were clarified at 150,000
x g for 2 to 3 h as previously described (27). From 0.5
to 1 ml of cell lysate was immunoprecipitated with 5
to 10 pl of normal or immune serum. Antigen-antibody
complexes were collected by binding to Staphylococ-
cus aureus (12). SDS-polyacrylamide gel electropho-
resis was performed on the discontinuous stacking
system of Laemmli (14).
Partial proteolytic digestion. Proteolytic diges-
tion was performed essentially as described by Cleve-
land et al. (4). The immunoprecipitated products were
separated by electrophoresis through SDS-polyacryl-
amide gels, and the bands of interest were cut out
from the wet gels. The fragments were washed several
times in 0.1% SDS-1 mM EDTA-0.125 M Tris buffer
(pH 6.8) and then applied to a second gel. S. aureus
V8 protease (Miles) and a-chymotrypsin at several
concentrations were added. The samples were concen-
trated at the interphase between the stacking and
running gel and stopped for 30 min at room tempera-
ture, and then electrophoresis was continued.
High-voltage electrophoresis of phosphoryl-
ated amino acids. Phosphorylated proteins were im-
munoprecipitated and further purified by precipitation
with trichloroacetic acid and washing in absolute al-
cohol. About 5,000 cpm of phosphate-labeled protein
was hydrolyzed for 2 to 6 h in 6 N HCI at 100°C.
Hydrolyzed samples were suspended in 5 pi of unla-
beled phosphoserine, phosphothreonine, or phospho-
tyrosine at a concentration of 1 mg/ml each. Samples
were analyzed by high-voltage electrophoresis in pyr-
idine-acetic acid (pH 3.5) on Whatman 3MM paper at
2,400 V for 1 h (28).
RESULTS
To compare the 50,000-molecular-weight pro-
tein found in A-MuLV-transformed cells with
that of SV40- or chemically transformed cells,
we studied the following cell lines: 2M3, an A-
MuLV-transformed lymphoid cell line; SVT2, a
BALB/3T3-derived, fibroblastic, SV40-trans-
forned cell line; and Meth A, a chemically in-
duced fibrosarcoma ofBALB/c origin. The three
cell lines were labeled for 1 h with [35S]methio-
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nine, and the cell lysates were immunoprecipi-
tated with a variety of antisera.
It was shown previously that mice carrying an
A-MuLV-induced tumor often make antibody to
the P50; we have called such P50-reactive sera
Ab-TB sera (23). When labeled cell extracts
were precipitated with an Ab-TB serum, the
three tested cell lines showed a strong band of a
50,000-molecular-weight protein (Fig. 1, lanes c).
Normal serum precipitated very little or no pro-
tein of this size (Fig. 1, lanes a). We show below
that these three 50,000-molecular-weight pro-
teins are closely related and probably identical;
they will henceforth be referred to as P50.
An antiserum made to the SV40-induced tu-
mor cell line precipitated a faint P50 band from
2M3, a strong band from the homologous tumor,
and a weak band from Meth A cells (Fig. 1, lanes
d). This behavior indicates that the majority of
the reactivity of this serum with the SV40-trans-
formed cell is a consequence of its reactivity
with the 95,000-molecular-weight T-antigen that
is known to be complexed to P50 in these cells
(15, 16, 18).
When an anti-Meth A serum was used to
precipitate extracts of the three cell lines, strong
bands of P50 were found (Fig. 1, lanes e). This
result confirms the serological identity of the
P50 in the three cell lines. The anti-Meth A
serum precipitated a strong band of T-antigen
from SVT2 cells, as did the Ab-TB serum, dem-
2M3 SV T 2 Met
a b c d e a b c d e a
P120- i
T-Ag-
P50- * :
onstrating again the tight association of T-anti-
gen with P50 in the SVT2 extracts.
Judging from the intensity of the bands, Meth
A cells have the most P50, and SVT2 and 2M3
have about equal amounts. Virtually all of the
P50 in SVT2 cells is complexed with T-antigen
because the anti-SVT2 serum, which is mainly
anti-T-antigen, brings down only slightly less
P50 than Ab-TB serum, which reacts directly
with P50. The different shape of the bands pre-
cipitated by the various sera and the apparent
differences in migration rate of the P50 proteins
are a consequence of the physical behavior of
the specific sera during electrophoresis and are
not differences intrinsic to the proteins.
As a control, extracts of the L1-2 cell line were
precipitated by the various sera. L1-2 is an A-
MuLV-transformed cell line of C57L origin that
lacked detectable P50 when assayed previously
with Ab-TB sera. It also lacked reactivity with
anti-SVT2 and anti-Meth A sera (Fig. 1).
Further tests of the identity between the three
P50s were performed by serially precipitating
with one serum and then a second. Once one
serum cleared P50 from an extract, the other
sera could not precipitate further P50 (data not
shown).
In previous studies the anti-P50 monoclonal
serum RA3-2C2 did not coprecipitate the A-
MuLV-encoded P120 protein (23). This result
was confirmed in the present work by the lack
h A L12
b c d e a b c d e
-P120
i.
-*. Pr80env
*; iv;E .
FIG. 1. Immunoprecipitation of P50 host protein from 2M3, SVT2, Meth A, and Ll-2 [35S]methionine-
labeled cell lysates. Equal numbers of counts per minute of 35S-labeled cell lysates from 2M3, SVT2, Meth A,
and Ll-2 cells were immunoprecipitated with the following sera: normal mouse serum (lanes a); anti-AbT
serum shown to immunoprecipitate the P120 ofA-MuLV (lanes b); Ab-TB serum obtained from BALBIc mice
bearing a syngeneic A-MuLV-induced tumor (lanes c); anti-SVT2 serum (lanes d); and anti-Meth A serum
(lanes e). Samples were processed as described in the text, and the products were analyzed by electrophoresis
through an SDS-polyacrylamide gel.
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of P120 in the anti-Meth A precipitate of the
2M3 cell extract. An anti-P120 serum also pre-
cipitated very little P50 from any of the cell lines
and, specifically, did not precipitate more P50
from 2M3 than from the other cells (Fig. 1, lanes
b). The anti-P120 serum had reactivity with a
high-molecular-weight protein in the fibroblast
transformed lines; this has been previously ob-
served with other such lines and represents a
protein that has not been identified. The anti-
P120 serum, as well as the Ab-TB serum, precip-
itated a band of Pr80en" from the L1-2 cells
because they were coinfected with helper Mo-
loney MuLV.
Comparison ofthe partial digestion prod-
ucts of P50 host protein obtained from the
different cell lines. Further comparison be-
tween the P50s of 2M3, SVT2, and Meth A cells
was carried out by analyzing the partial proteo-
lytic digestion products of P50 obtained from
the different sources. [35S]methionine-labeled
extracts were immunoprecipitated with Ab-TB
serum, the P50 proteins were resolved by SDS-
polyacrylamide gel electrophoresis, and the P50
bands were excised from the wet gels. The bands
were applied to a second gel and digested with
various concentrations of S. aureus V8 protease.
The three P50s gave identical partial digestion
patterns (Fig. 2). Identical patterns of proteo-
lytic products were also observed when P50 of
2M3, SVT2, or Meth A cells, immunoprecipi-
tated with Ab-TB serum, was treated with a-
chymotrypsin (Fig. 3). When each of the cell
2M3
lines was immunoprecipitated with the serum
specific to that line, the P50 molecules presented
the same pattern of proteolytic products when
digested with V8 protease (results not shown).
Thus the various P50s appear identical at this
level of resolution.
Phosphorylation of P50 host protein and
characterization of the phosphate-protein
bond. We have shown previously that the P50
in 2M3 cells is a phosphoprotein (23). To ex-
amine whether the P50 found in SVT2 and Meth
A cells was also phosphorylated, the lines were
labeled for 5 h with 32pO4, and lysates were
immunoprecipitated with either normal mouse
serum (Fig. 4, lanes A), RA3-2C2, a monoclonal
anti-P50 antibody (23) (lanes B), Ab-TB serum
(lanes C), or anti-P120 serum (lanes D). Phos-
phorylated P50 was present in all of these cell
lines. These antibodies were also able to immu-
noprecipitate the phosphorylated form of large
T-antigen from SVT2 cells, reflecting the com-
plex of this protein with P50. Although anti-
P120 precipitated a heavy band of phosphoryl-
ated P120 from 2M3 cells, the monoclonal anti-
P50 precipitated no more P120 than did normal
serum. From Meth A cells, no protein other than
P50 was evident in the immunoprecipitates.
Thus, no other phosphorylated proteins are
tightly bound to P50 in either the A-MuLV-
transformed cells or the Meth A cells.
Recently it was shown that the transforming
proteins of various viruses are phosphorylated
on a tyrosine residue (10, 28). To examine the
SVT 2
a b c d a b c d
Meth A
a b c d
P50- I _
_2 _0
~ ~ ~ 4
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FIG. 2. Comparison ofpartial proteolytic products, digested with S. aureus V8, of P50 obtained from 2M3,
SVT2, and Meth A cell lysates. The different cell lysates were immunoprecipitated with Ab-TB serum, and the
P50 bands were cut out from the wet gel, washed in 0.1% SDS-125 mM Tris buffer (pH 6.8)-i mM EDTA, and
loaded on a second SDS-polyacrylamide gel. The individual lanes were treated with no enzyme (lanes a), or
10 ng (lanes b), 20 ng (lanes c), or 40 ng (lanes d) of V8 protease. Samples were collected at the interphase
between the stacking and the running gel, the current was stopped for 30 min to let digestion occur, and then
electrophoresis was continued.
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2M3 SVT2 MethA
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FIG. 3. Comparison ofpartialproteolytic products
of P50, obtained from 2M3, SVT2, and Meth A cell
lysates and digested with a-chymotrypsin. No enzyme
(lanes A); 100 pg of a-chymotrypsin per lane (lanes
B). The samples were handled as described for Fig.
2.
2M3 SV T 2 Meth A
A B C D A B C D A B C D
P-120- io *
T-Ag- i r
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FIG. 4. Phosphorylation of P50 in vivo. 2M3,
SVT2, and Meth A cells were labeled with 32p04 for
5 h, and cell lysates were immunoprecipitated with
the following sera: normal serum (lanes A); RA3-2C2
monoclonal antibodies recognizing the P50 (lanes B);
Ab-TB serum (lanes C); and anti-AbT serum (lanes
D). Samples were treated as described for Fig. 1.
site of phosphorylation in P50, P50 from 32p_
labeled 2M3 cells was immunoprecipitated with
the monoclonal RA3-2C2 antibody, acid hydro-
lyzed, and analyzed by high-voltage electropho-
resis at pH 3.5. As controls, we examined the
phosphoamino acids released from in vivo-la-
beled P120, in vitro-labeled P120 (a phosphoty-
rosine marker; 28), and the product of a cyclic
AMP-dependent kinase (a phosphoserine
marker). The different phosphorylated proteins
were precipitated with trichloroacetic acid,
washed with absolute alcohol, and hydrolyzed.
After various times of hydrolysis, the major
phosphoamino acid released from P50 comi-
grated with phosphoserine (Fig. 5, lanes A, B,
and C). In addition, a heavy spot of free radio-
active orthophosphate was also detected. A mi-
nor spot of phosphothreonine was also detected,
but no phosphotyrosine was found. The spot
migrating just ahead of the phosphotyrosine
marker was UMP (2, 22); a spot of CMP was
also present near the origin. These either were
A B C D E F G H I
P04-00 *** * * 0
P-Ser-441 *m* *P-Ser
P-Thr- toP e -r
* !tP-Tyr- * * *
*t
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.
i
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FIG. 5. Characterization of the phosphoamino
acids in P50. 2M3 cells were labeled with 32PO4 (300
,uCi/ml) for 16 h in medium devoid of P04 and en-
riched with 5% fetal calf serum. Cell lysates were
immunoprecipitated with RA3-2C2 monoclonal anti-
bodies, and samples of about 5,000 cpm were hydro-
lyzed in 6 N HCI at 100°C for 6 h (lane A), 4 h (lane
B), or 2 h (lane C). Samples were applied to 3MM
paper and run in pyridine-acetic acid buffer (pH 3.5)
at 2,400 V for 1 h. For analyzing the phosphoamino
acids of P120 labeled in vivo, the above cell lysates
were immunoprecipitated with anti-AbT serum, and
samples were hydrolyzed for 6 h (lanes D), 4 h (lane
E), and 2 h (lane F). For a phosphotyrosine marker,
P120 was allowed to label itself in vitro (28) and
hydrolyzed for 2 h (lane G). A phosphoserine marker
was provided by the cyclic AMP-dependent kinase
acting under in vitro conditions (lane H). A purified
P50 was obtained by electroelution from an SDS-
polyacrylamide gel. About 800 cpm of purified P50
was hydrolyzed for 2 h, and the autoradiogram was
exposed for 8 days (lane I). Each of the hydrolyzed
samples was mixed with unlabeled phosphoserine,
phosphothreonine, andphosphotyrosine marker, and
the electrophoresis paper was stained with ninhydrin
for the location of markers.
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contaminants from RNA or were released from
protein by the acid.
In agreement with our previous report (28),
the major phosphoamino acid from in vivo-la-
beled P120 was phosphoserine, but some phos-
photyrosine and phosphothreonine was ob-
served (Fig. 5, lanes D, E, and F). As expected,
P120 phosphorylated in vitro yielded only phos-
photyrosine (Fig. 5, lane G), and cyclic AMP-
dependent kinase yielded phosphoserine (Fig. 5,
lane H).
To confirm that P50 immunoprecipitated by
RA3-2C2 monoclonal antibody gave identical
results to that immunoprecipitated by Ab-TB
serum, 32P04-labeled 2M3 cell lysates were im-
munoprecipitated with Ab-TB serum. In this
case, the specific proteins were separated by
electrophoresis, and the radioactive P50 was ex-
cised and electroeluted. Hydrolysis of the puri-
fied P50 protein yielded a single spot of radio-
active phosphoserine and free orthophosphate
(Fig. 5, lane I), further indicating the P50 is
phosphorylated in vivo only at a serine residue.
We have not been able to phosphorylate the P50
under in vitro conditions either in a soluble
reaction or when immunoprecipitated with Ab-
TB serum and adsorbed onto S. aureus particles.
Localization of P50. To localize P50 in the
cells, a number of lines were examined using
immunofluorescence with both an Ab-TB serum
and the monoclonal anti-P50 (Fig. 6). When
tested on live cells for surface P50 and on fixed
cells for intracellular P50, both reagents pro-
duced the same staining patterns (Table 1). Con-
sistent with previous determinations (Coffiman
and Weissman, submitted for publication), a
small percentage of thymus cells (<3%) and 30%
of spleen cells had a P50-related surface protein
(Fig. 6, A and B). By double labeling with an
anti-mouse immunoglobulin reagent, the P50-
positive cells were shown to have surface im-
munoglobulin and thus were B-lymphocytes. No
intracellular fluorescence could be detected in
these cells. Coffman and Weissman originally
chose the monoclonal anti-P50 because it rec-
ognized a B-lymphocyte-specific antigen (see
reference 23), and the present work thus con-
firms their data.
When lymphoid, A-MuLV-transformed cells
were examined, surface staining was evident
(Fig. 6, C and D), but the rounded morphology
of the cells prevented detection of intracellular
fluorescence. Because the A-MuLV-transformed
lymphoid cells are related to pre-B-lymphocytes,
a similar cell line derived by chemical treatment
of mice, 70Z, was examined and found to have
surface fluorescence with the monoclonal anti-
body (Table 1). Immunoprecipitation studies
had previously shown that 70Z had a very low
level of P50; in this way, 70Z is like the A-MuLV
lymphoid transformant L1-2, which has very
little immunoprecipitable P50 (23) but a strong
surface fluorescence with the monoclonal anti-
body (Table 1).
To examine whether the majority of the P50
in A-MuLV-transformed lymphoid cells might
be in the cytosol rather than attached to mem-
branes, a [35S]methionine-labeled 2M3 extract
was fractionated into nucleus, total membranes,
and cytosol. The various fractions were then
immunoprecipitated with either normal serum
(Fig. 7, lanes A), the RA3-2C2 monoclonal anti-
P50 (lanes B), or anti-Moloney MuLV serum (to
precipitate the A-MuLV P120) (lanes C). The
P50 protein was largely in the cytosol, with
minor amounts in the other cell fractions. By
contrast, P120 was mainly recovered in the nu-
clear and membrane fractions, consistent with
its previous localization in the plasma membrane
(29).
When fibroblastic, A-MuLV transformants
were examined by immunofluorescent tech-
niques, a different picture emerged. No surface
antigen was detectable on any fibroblastic cells
(Table 1). When uninfected NIH/3T3 cells were
fixed and stained, however, normal serum
showed no reactivity (Fig. 6, E and F), but the
anti-P50 reagent showed a granular, cytoplasmic
fluorescence (Fig. 6, G and H). The SV40-trans-
formed line SVT2 showed a much more brightly
staining pattern of cytoplasmic, granular fluo-
rescence (Fig. 6, I and J). In the SV40-trans-
formed cells, the possibility of nuclear antigen
cannot be excluded because the bright cytoplas-
mic staining makes it difficult to judge whether
the nucleus has background staining or a real
signal. Others have described the occurrence of
P50 in the nucleus of SV40-transformed cells (8,
19), and we have confirmed that in an SV40-
transformed CV-1 monkey cell line (7), there is
preponderant nuclear staining. Furthermore, we
have confirmed that in SVT2 the T-antigen
staining was mainly nuclear but that some gran-
ular cytoplasmic staining was also evident. Thus,
we conclude that in normal fibroblasts, P50 can
be a cytoplasmic protein concentrated in vesi-
cles; in SV40-transformed cells it is apparently
often carried into the nucleus probably because
of its association with T-antigen (8, 19).
The A-MuLV-transformed fibroblastic line,
ANN-1, and the Meth A cell line did not stain
for P50 in our hands, although it is clear that
both lines possess P50. A possible explanation
for this observation is that both lines have a
very transformed morphology and do not spread
out well compared to untransformed fibroblasts.
When cells display a rounded-up morphology,
the P50 protein might become so dispersed
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FIG. 6. Localization of P50 by immunofluorescence. Cells were labeled for the presence of P50 either as
living suspensions or as fixed monolayers by using the monoclonal or murine reagents. (A) Phase contrast of
BALBIc spleen cells labeled in suspension with monoclonal anti-P50. (B) Spleen cell fluorescent profile with
anti-P50. (C) Phase contrast of2M3 cells labeled in suspension with monoclonal anti-P50. (D) 2M3 fluorescent
profile with anti-P50. (E) Phase contrast offixed NIH/3T3 fibroblasts labeled with normal mouse serum and
rhodamine-labeled rabbit anti-mouse immunoglobulin serum. (F) NIH/3T3 normal mouse serum fluorescent
profile. (G) Phase contrast ofNIH/3T3 fibroblasts labeled with Ab-TB serum. (H) NIH/3T3 fibroblast profile
with Ab-TB serum. (I) Phase contrast of SVT2 fibroblasts labeled with Ab-TB serum. (J) SVT2 fluorescent
profile with Ab-TB serum.
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TABLE 1. Distribution ofP50 as assessed by immunofluorescence
Location of fluorescence
Cell type Surface Cytoplasm Nucleus
Ab-TBa 2C2b Ab-TB 2C2 Ab-TB 2C2
BALB/c thymus NDc + (1-3%) ND - ND -
BALB/c spleen ND + (30%) ND - ND
2M3 + + - - - -
70Z ND + ND ND ND ND
Ll-2 + + ND ND ND ND
NIH/3T3 - - + + - -
SVT2 - - +++ +
MethA --A
ANN-1 - - - - - -
a Ab-TB serum is the serum from a BALB/c mouse carrying a transplanted A-MuLV-induced syngeneic
tumor. Such sera are selected for a high anti-P50 reactivity.
b 2C2 is the monoclonal anti-P50 rat serum RA3-2C2.
c ND, Not done.
Nucleus Membrones Cytosol
A B C A B C A B C
wv a~~~~ ~~~~W- 120
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FIG. 7. Distribution of P50 and P120 in different
cell fractions. [35S]methionine-labeled 2M3 cells were
fractionated according to the method of Hay (9).
Briefly, cells were allowed to swell for 10 min at 40 C
in 10 mM Tris (pH 7.4)-l mM MgCl2, followed by
Dounce homogenization. Nuclei and large cell frag-
ments were removed by centrifugation at 1,000 x g
for 5 mi (nucleus), and the supernatant was further
clarified at 100,000 x g for 60 min to yield a pellet
(membranes) and the supernatant (cytosol). Each of
the fractions was immunoprecipitated with normal
(A), RA3-2C2 anti-P50 (B), and goat anti-Moloney
MuLV (C) sera.
through the cytoplasm that the immunofluores-
cent staining would not be clearly distinct from
background staining. Melero et al. (19) reported
that Meth A cells had a nuclear 48,000-molecu-
lar-weight, T-antigen-associated protein; the re-
lationship of their data to the present observa-
tions is uncertain.
Association of the surface P50-related
protein and P120. We approached the question
of whether the surface P50-related protein and
P120 were associated by investigating whether
the two proteins would cocap on A-MuLV-trans-
formed lymphoid cells. Using the 2M3 cell line,
we first demonstrated that the fluorescent sec-
ond antibodies used contained no cross-reacting
activities. The fluoresceinated rabbit anti-rat
immunoglobulin serum was found to label only
cells previously incubated with the monoclonal
anti-P50 reagent. Similarly, the rhodaminated
rabbit anti-mouse immunoglobulin serum only
labeled cells previously incubated with mouse
anti-AbT serum (anti-P120; 29) and not anti-P50
or normal serum. In addition, the fluorescent
antibodies did not cross-react with each other.
When 2M3 cells were separately capped for
either P50 or P120 proteins and restained, using
a different fluorochrome for the other protein
under noncapping conditions, an identical fluo-
rescence pattern was observed irrespective of
which protein was first capped. A fraction of the
two proteins was found to be localized to the
same parts of the cell surface, and a fraction was
found to be independent (Fig. 8). This finding
suggests that some of both the P120- and P50-
related proteins is associated with the other
protein, and some is not associated or so weakly
associated that the two do not cocap. As a con-
trol, cocapping of Moloney MuLV gp7O and the
P50-related protein was studied on an A-MuLV-
transformed, producer cell line, 2M3/M. No as-
sociation at all of the two antigens was evident
in either direction. Thus, the partial cocapping
of P120 and the P50-related protein is meaning-
ful because it is distinguishable from a case
where no association is evident.
DISCUSSION
It has previously been shown by others that
an approximately 50,000-molecular-weight pro-
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FIG. 8. Association ofP50 and P120 proteins showing partial cocapping of the two proteins. P50 proteins
on 2M3 cells were capped by using monoclonal rat anti-P50 followed by fluorescein-labeled rabbit anti-rat
immunoglobulin serum. Cells were then restained under noncapping conditions for thepresence ofP120, using
mouse anti-AbT serum and rhodamine-labeled rabbit anti-mouse immunoglobulin serum. (A) Phase contrast.
(B) P50 fluorescein staining. (C) P120 rhodamine staining.
tein has a greatly increased concentration in
cells transformed by a variety of means (5, 11).
This protein is one that associates tightly with
T-antigen of SV40 and has been called nonviral
T-antigen (15, 16, 18). We had previously shown
that mice carrying or rejecting an A-MuLV-in-
duced lymphoid tumor make high concentra-
tions of anti-P50 antibody (23). That antibody
reacts with a prominent cell surface antigen of
the A-MuLV-induced lymphoid tumor cells. The
present evidence shows that the P50 of A-
MuLV-transformed lymphoid cells, which is also
increased in A-MuLV-transformed fibroblastic
cells, has the same pattern of partial protease
digest products as the nonviral T-antigen of an
SV40-transformed cell line and the 50,000-mo-
lecular-weight antigen of a methylcholanthrene-
transformed BALB/3T3 cell line. Furthermore,
antibodies made to the A-MuLV-, SV40-, and
methylcholanthrene-transformed cell lines each
precipitated P50 proteins from all three types of
transformed cells. Also, a monoclonal antibody
to the A-MuLV-associated P50 protein reacted
with the P50s from the other cell lines. Even
Rous sarcoma virus-transformed mouse cells
have a significant level of the same P50 found in
other transformed cells, but the 50,000-molecu-
lar-weight protein that coprecipitates with the
pp60src transforming protein of Rous sarcoma
virus (10) appears to differ from the P50 protein
described here (Rotter, unpublished data).
Thus, closely related and presumably identical
P50 proteins are found at increased concentra-
tion in many tumor cells, including both lymph-
oid and fibroblastic cell types. The P50 probably
has some key relationship to the transformed
state.
The subcellular localization of the P50 protein
in different cells presents a puzzle. It is clearly a
B-lymphocyte cell surface differentiation anti-
gen (R. Coffman and I. Weissman, manuscript
in preparation; confirmed by the staining of nor-
mal cells in the present work). It is, however,
evident in thymocytes although not on them (11,
23). It is present in the cytoplasm of NIH/3T3
cells and at increased levels in the nucleus or
cytoplasm of various SV40-transformed fibro-
blastic cells. Its localization by fluorescence
methods in A-MuLV-transformed cells or chem-
ically transformed cells was not possible in our
studies because intracellular proteins in these
rounded cells were difficult to examine by im-
munofluorescence; had the protein been in the
nucleus it should probably have been visible,
and therefore it is probably not concentrated in
the nucleus. Cell fractionation studies on lymph-
oid cells showed P50 to be a soluble protein of
the cytosol. It would seem that the protein is a
cell surface protein in normal B-lymphoid cells,
is greatly increased in the cytosol of certain
transformed lymphoid cells, is a cytoplasmic
protein in fibroblastic cells, and can be drawn
into the nucleus in SV40-transformed cells prob-
ably because of its association with SV40 T-
antigen. Its localization to cytoplasmic granules
requires further study to determine the nature
of the granules. The protein has a short half-life
in cells (Rotter and Baltimore, unpublished
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data), and it could be that the granules are
lysosomes. The readily detectable fluorescence
in NIH/3T3 cells, although less than that in
SV40-transformed cells, seems more than might
have been expected from the low level of inl-
munoprecipitable protein in such cells; possibly,
the antibody is detecting fragments of the pr -
tein in the process of degradation.
It is clear that P50 in lymphoid cells is not alll
surface localized; in fact, the vast majority was
found free in the cytosol. Because of the diffi-
culty of visualizing P50 in rounded cells, there
must be quite high concentrations of P50 in the
cytoplasm of lymphoid cells that are not de-
tected by fluorescence methods. The discord-
ance of surface antigen and total P50 is best
shown by the lack or low level of immunoprecip-
itable P50 in 70Z and L1-2 cells, lines that have
a brightness of surface fluorescence equivalent
to those of 2M3 and other high-P50 A-MuLV
transformants. This suggests that the proteins
with P50 antigenicity in different locales and
different cells may be different molecules. In
fact, the possibility exists that the antigen on
the B-lymphocyte surface is not the P50 at all
but is a cross-reactive protein. The strong reason
for saying that the P50 is related to the surface
antigen is their common antigenicity as revealed
both by a monoclonal serum and by a series of
sera from tumor-bearing animals.
A-MuLV transformation clearly enhances P50
concentration in fibroblastic cells (23). It could
be that A-MuLV transformation also enhances
cytoplasmic P50 in lymphoid transformants and
that 70Z has so little P50 because it was not
transformed by A-MuLV. L1-2 was transformed
by A-MuLV but does not have an enhanced P50
level; however, its lack of P50 is a unique obser-
vation among many A-MuLV transformants we
have examined, and it is also unique in being
rejected by syngeneic animals.
P50 is a phosphorylated protein in both fibro-
blastic and lymphoid cells (3, 11, 16, 18; present
studies). The phosphate is linked to a serine
residue, at least in the A-MuLV-transformed
lymphoid cell P50. Thus, the kinase activity
associated with the A-MuLV transforming pro-
tein, which makes only phosphotyrosine bonds
in the A-MuLV protein itself, either is not active
on the P50 or has a different amino acid speci-
ficity when acting on P50; most likely P50 is not
a substrate for the A-MuLV kinase. Also, no
labeling of P50 in vitro could be shown in im-
munoprecipitates of P50.
The partial linkage of the surface P50-related
protein to the A-MuLV protein revealed by the
cocapping experiments suggests a weak associa-
tion of the two proteins. Immunoprecipitation
experiments, done under the fairly harsh condi-
tions ofthe immunoprecipitation buffer solution,
have not shown any indication of an association.
We conclude that the proteins weakly interact
at the cell surface, but the significance of the
interaction is unclear. It is equally unclear what
the tight association of T-antigen and P50 sig-
nifies. P50 is an unusual protein in that it has a
half-life of only a few hours in the cell (Rotter
and Baltimore, unpublished data). This raises
the possibility that some of the differences in
steady-state concentration may be a conse-
quence of changes in half-life of the protein.
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